BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28469908)

  • 1. Measuring and improving cervical, breast, and colorectal cancer screening rates in a multi-site urban practice in Toronto, Canada.
    Feldman J; Davie S; Kiran T
    BMJ Qual Improv Rep; 2017; 6(1):. PubMed ID: 28469908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
    Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
    JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using self-reported data on the social determinants of health in primary care to identify cancer screening disparities: opportunities and challenges.
    Lofters AK; Schuler A; Slater M; Baxter NN; Persaud N; Pinto AD; Kucharski E; Davie S; Nisenbaum R; Kiran T
    BMC Fam Pract; 2017 Feb; 18(1):31. PubMed ID: 28241787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mailed Letter Versus Phone Call to Increase Uptake of Cancer Screening: A Pragmatic, Randomized Trial.
    Kiran T; Davie S; Moineddin R; Lofters A
    J Am Board Fam Med; 2018; 31(6):857-868. PubMed ID: 30413542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: results from a pragmatic cluster randomized controlled trial.
    Clouston K; Katz A; Martens PJ; Sisler J; Turner D; Lobchuk M; McClement S; Crow G;
    BMC Cancer; 2014 Apr; 14():263. PubMed ID: 24739235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-visit-based cancer screening using a novel population management system.
    Atlas SJ; Zai AH; Ashburner JM; Chang Y; Percac-Lima S; Levy DE; Chueh HC; Grant RW
    J Am Board Fam Med; 2014; 27(4):474-85. PubMed ID: 25002002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding those overdue for cancer screening by five years or more: A retrospective cohort study in Ontario, Canada.
    Lofters AK; Kopp A; Vahabi M; Glazier RH
    Prev Med; 2019 Dec; 129():105816. PubMed ID: 31445111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Practice Facilitation and Academic Detailing Intervention Can Improve Cancer Screening Rates in Primary Care Safety Net Clinics.
    Mader EM; Fox CH; Epling JW; Noronha GJ; Swanger CM; Wisniewski AM; Vitale K; Norton AL; Morley CP
    J Am Board Fam Med; 2016; 29(5):533-42. PubMed ID: 27613786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical Trial.
    Atlas SJ; Tosteson ANA; Wright A; Orav EJ; Burdick TE; Zhao W; Hort SJ; Wint AJ; Smith RE; Chang FY; Aman DG; Thillaiyapillai M; Diamond CJ; Zhou L; Haas JS
    JAMA; 2023 Oct; 330(14):1348-1358. PubMed ID: 37815566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol.
    Clouston K; Katz A; Martens PJ; Sisler J; Turner D; Lobchuk M; McClement S;
    BMC Cancer; 2012 May; 12():182. PubMed ID: 22607726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.
    Kiran T; Davie S; Singh D; Hranilovic S; Pinto AD; Abramovich A; Lofters A
    Can Fam Physician; 2019 Jan; 65(1):e30-e37. PubMed ID: 30674526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Program to improve colorectal cancer screening in a low-income, racially diverse population: a randomized controlled trial.
    Jean-Jacques M; Kaleba EO; Gatta JL; Gracia G; Ryan ER; Choucair BN
    Ann Fam Med; 2012; 10(5):412-7. PubMed ID: 22966104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of non-adherence to breast, cervical, and colorectal cancer screening among screen-eligible women: a population-based cohort study in Ontario, Canada.
    Vahabi M; Lofters AK; Kopp A; Glazier RH
    Cancer Causes Control; 2021 Feb; 32(2):147-155. PubMed ID: 33392906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders.
    Baron RC; Melillo S; Rimer BK; Coates RJ; Kerner J; Habarta N; Chattopadhyay S; Sabatino SA; Elder R; Leeks KJ;
    Am J Prev Med; 2010 Jan; 38(1):110-7. PubMed ID: 20117566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving breast and colon cancer screening rates: a comparison of letters, automated phone calls, or both.
    Phillips L; Hendren S; Humiston S; Winters P; Fiscella K
    J Am Board Fam Med; 2015; 28(1):46-54. PubMed ID: 25567822
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.